About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PRO Survivorship Concerns ITA

NCT06080607·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Patrizia Pugliese
CONTACT
+39 06 52666155 patrizia.pugliese@ifo.gov.it
Chiara Falcicchio
CONTACT
+39 06 52666155 chiara.falcicchio@ifo.it

Lead

Regina Elena Cancer Institute

With

Centro di Riferimento Oncologico - Aviano
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
Istituti Tumori Giovanni Paolo II
Fondazione Salvatore Maugeri

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

During transcultural adaptability 80 representative patients will be recruited .
During the validation phase previus patients will be included and more other patients will be included (at least 280)

You may not be if

Patients with cognitive or memory impairment wil be excluded

The record

StatusUnknown

PhaseNo phase

Taking part280

StartedJan 2022

UpdatedMar 25, 2024

Conditions

Breast Neoplasm Female Quality of Life Psychological Distress

Where2

Regina Elena Cancer Institute
Rome, Roma, Italy
"Regina Elena" National Cancer Institute
Rome, Italy

Clareo Health | PRO Survivorship Concerns ITA